Author Affiliations: The Zena and Michael A.
Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York,
Identification of patients at risk for sudden cardiac death (SCD) is
a major challenge for the medical community. Although there have been advances
in the area of risk stratification, it remains troubling that the majority
of individuals who die of SCD are among a population that is not identified
by current methods of risk stratification.1 Nevertheless,
several recent trials have attempted to identify groups of patients who may
benefit from an implantable cardioverter-defibrillator (ICD).
Gehi A, Haas D, Fuster V. Primary Prophylaxis With the Implantable Cardioverter-DefibrillatorThe Need for Improved Risk Stratification. JAMA. 2005;294(8):958-960. doi:10.1001/jama.294.8.958